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Freshly isolated peripheral blood monocytes lack fo-
cal adhesion kinase (p125FAK) but activate a second
member of this kinase family, calcium-dependent tyro-
sine kinase (CADTK; also known as Pyk2/CAKb/RAFTK/
FAK2), upon adhesion or stimulation with chemokines.
To study the role of CADTK in monocyte adherence and
motility, we performed immunocytochemical localiza-
tion that showed CADTK at the leading edge and ruf-
fling lamellipodial structures in freshly isolated, ad-
hered human monocytes. We next introduced CADTK/
CAKb-related non-kinase (CRNK), the C-terminal
noncatalytic domain of CADTK, into monocytes by elec-
troporation and showed that it inhibited CADTK auto-
phosphorylation. Introduction of the fusion protein glu-
tathione S-transferase (GST)-CRNK also reduced (i) cell
spreading, as reflected in a reduced cell area 30 min
after adhesion, (ii) adhesion-induced phosphotyrosine
increases and redistribution into lamellipodia, and (iii)
adhesion-induced extracellular signal-regulated pro-
tein kinase (ERK) activation. In control experiments,
introduction of GST or GST-C3 transferase (an inhibitor
of RhoA GTPase activity) by electroporation did not
affect these parameters. Monocytes adhered in the pres-
ence of autologous serum were highly motile even after
introduction of GST (83% motile cells). However, only
26% of monocytes with introduced GST-CRNK were mo-
tile. In contrast, GST-CRNK-treated monocytes were
fully capable of phagocytosis and adhesion-induced cy-
tokine gene induction, suggesting that CADTK is not
involved in these cellular activities and that GST-CRNK
introduction does not inhibit global monocyte func-
tions. These results suggest that CADTK is crucial for
the in vitro monocyte cytoskeletal reorganization neces-
sary for cell motility and is likely to be required in vivo
for recruitment to sites of inflammation.
Integrin-mediated monocyte adhesion to extracellular ma-
trix or endothelial monolayers results in a dramatic alteration
of the cytoskeleton and rapid transcriptional activation of nu-
merous genes required in the inflammatory response (1–6).
Monocytes adhered in the absence of any chemotactic stimuli
fail to polarize and maintain a radial symmetry while exhibit-
ing continuous but moderate membrane ruffling (7).1 In con-
trast, monocytes adhered in the presence of either chemotactic
stimuli or autologous serum will rapidly polarize and migrate
(9, 10). Migration requires both contractile and protrusive
events, mediated by changes in the actin cytoskeleton (7). Al-
though several lamellipodia are extended simultaneously, di-
rectional movement is obtained by the development of a dom-
inant lamellipodium protruding in response to a concentration
gradient (7).
Focal adhesion kinase (p125FAK)2 often coordinates integrin-
mediated cell migration in nonhematopoetic cells (10, 11). After
adhesion, p125FAK is targeted to focal adhesions, where it co-
localizes with integrins and becomes activated and phosphoryl-
ated on multiple tyrosine residues. p125FAK serves as both a
kinase and as a structural protein capable of binding other
proteins in a phosphotyrosine-dependent (e.g. src or Grb2) and
-independent (e.g. paxillin) manner (11, 12). In an alternatively
spliced form of p125FAK, FRNK, the C-terminal noncatalytic
domain has been used to identify the role of p125FAK in motil-
ity, presumably because its experimental overexpression dis-
places p125FAK from its site of action. For example, FRNK
expression in endothelial cells blocked migration (13). In addi-
tion, fibroblasts isolated from p125FAK 2/2 knockout mice had
reduced motility (14), whereas ectopic expression of p125FAK in
p125FAK-null cells dramatically enhanced cell spreading and
migration (15, 16). The mechanism by which p125FAK promotes
cell migration is, however, still not clear.
A second member of the p125FAK family has been identified,
the calcium-dependent tyrosine kinase CADTK (17), also
known as Pyk2, CAKb, RAFTK, and FAK2 (18–21). CADTK
and p125 FAK are coexpressed in many epithelial, some mesen-
chymal, and hematopoetic cells and presumably have comple-
mentary functions. In contrast to fibroblasts and epithelial
cells, freshly isolated peripheral blood monocytes do not form
typical focal adhesions and totally lack p125FAK transcripts
and protein (22, 23). Monocytes do express CADTK, (23) a
cytoskeletal associated kinase of this family, as a splice variant
that deletes 42 amino acids in the first proline-rich domain,
reducing the approximate molecular mass from 115 to 110 kDa.
This variant has been observed in other cell types as well (24,
* This work was supported by National Institutes of Health Grants
1-P60-DE13079 (NIDCR), AI26774 (to J. S. H.), and CA81503 (to
H. S. E.). The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 919-966-1573;
Fax: 919-966-3015; E-mail: hse@med.unc.edu.
1 O. I. Sirenko, U. Bocker, J. Morris, S. Haskill, and J. M. Watson,
submitted for publication.
2 The abbreviations used are: p125FAK, p125 focal adhesion kinase;
CADTK, calcium-dependent tyrosine kinase; CRNK, CADTK/CAKb-
related non-kinase; FRNK, FAK-related non-kinase; JNK, c-Jun N-
terminal kinase; ERK, extracellular signal-regulated protein kinase;
GST, glutathione S-transferase; PTP1B, protein tyrosine phosphatase
1B; PBS, phosphate-buffered saline; MAP kinase; mitogen-activated
protein kinase; PIPES, 1,4-piperazinediethanesulfonic acid; FITC, flu-
orescein isothiocyanate.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 5, Issue of February 2, pp. 3536–3542, 2001
© 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org3536
This is an Open Access article under the CC BY license.
25). Unlike p125FAK, which is constitutively phosphorylated in
adherent cells, in resting adherent epithelial and mesenchymal
cells CADTK is predominantly unphosphorylated. Agonists,
which raise intracellular calcium, activators of G-protein-cou-
pled receptors, and other signals such as protein kinase C
induce CADTK tyrosine autophosphorylation (17, 18, 26–28).
We and others (23, 29) show that adhesion or other stimuli
activate monocyte CADTK tyrosine phosphorylation. There are
complexities to adherence-induced activation of CADTK, as
adherence to tissue culture dishes provides a stronger stimulus
than adhesion to fibronectin-coated surfaces (23). CADTK as-
sociates with cytoskeletal proteins such as paxillin, Hic-5 (31),
and leupaxin (32) through conserved “LD” motifs, (33), found in
all three proteins. CADTK activation results in paxillin tyro-
sine phosphorylation in rat hepatic epithelial (30) and other
cells (34, 35) and may well be involved in tyrosine phosphoryl-
ation of leupaxin (32). CADTK immunolocalization varies by
cell type. Immunolocalization demonstrated CADTK in a con-
centric pattern, like that of actin in rat hepatic epithelial cells,3
along actin stress fibers and in focal adhesions in rat smooth
muscle cells (27) and diffusely throughout the cell when over-
expressed in fibroblasts (36).
A number of recent studies report CADTK/Pyk2 tyrosine
phosphorylation in cells of hematopoetic origin, e.g. T and B
lymphocytes (37–39), monocytes (23, 29), NK cells (34, 40, 41),
granulocytes (42), bone marrow progenitors (43), mast cells
(44), megakaryocytes (45), and platelets (46, 47). The stimuli
that trigger CADTK in these cells are often associated with cell
motility or at least cytoskeletal rearrangement. However, the
downstream targets of CADTK activation and its role in hema-
topoetic cell cytoskeletal rearrangement are unknown. In other
cell types, CADTK has been implicated in the activation of
ERK, JNK, and p38 MAP kinases (18, 26, 48). Monocytes
constitutively express a detectable level of activated p38 MAP
kinase and rapidly activate ERK and JNK kinases upon adhe-
sion (6). However these activations are transient in motile
monocytes adhered in the presence of autologous serum.1
The present work supports a role for CADTK in monocyte
motility first by showing that CADTK immunolocalized to the
leading edge ruffling lamellipodia. Taking a cue from studies of
the role of p125FAK in adhesion and motility and its inhibition
by FRNK (36), we inhibited CADTK function by introducing a
homologous protein referred to as CRNK (36, 49), beginning at
an initiating methionine (CADTK Met-685) in a position simi-
lar to that of FRNK (36). This encompasses areas of the proline-
rich region to the C terminus. In freshly isolated monocytes,
GST-CRNK blocked adhesion-induced CADTK autophospho-
rylation and also resulted in dramatic inhibition of cell spread-
ing, a loss of cell motility, and blockade of tyrosine phosphoryl-
ation redistribution. Although GST-CADTK had no effect on
JNK activation, GST-CRNK introduction did block adhesion-
induced ERK activation. Importantly, introduction of other
GST proteins did not produce the same results, and GST-
CRNK inhibited monocyte motility without altering monocyte
phagocytosis or adhesion-dependent transcriptional activation
of cytokine genes. These results suggest that CADTK regulates
cytoskeletal reorganization and motility but is not required for
all adhesion-dependent functions.
MATERIALS AND METHODS
Isolation of Monocytes and Culture Conditions—Human monocytes
were isolated from healthy volunteer donors as described previously (5)
by centrifugation through Ficoll/Histopaque 1077 (Sigma) and a Percoll
(Amersham Pharmacia Biotech) step gradient (50). Monocytes were
adherently cultured in endotoxin-free RPMI 1640 medium at 37 °C and
5% CO2. To produce polarized cells, monocytes were cultured in 5%
autologous serum (9). Monocyte motility was assessed using 20-s frame-
time lapse microphotometry with a 403 phase objective and the NIH
Image Movie program. Monocytes were studied for 70 frames.
Immunostaining—Cells were adhered for 30 min, fixed in 4%
paraformaldehyde in PBS (pH 7.5) for 10 min, and permeabilized with
0.2% Triton X-100 for 5 min at room temperature. Cells were blocked
with 25% normal goat serum in PBS for 30 min at room temperature,
washed in PBS, and incubated with BodipyFL-phallacidin (Molecular
Probes) diluted 1:20 with 25% goat serum in PBS for 30 min at room
temperature. For the detection of CADTK, cells were stained with
purified rabbit polyclonal anti-CADTK antibody (1:50–1:200). The anti-
CADTK #72 antiserum was raised against amino acids 660–880 of
CADTK expressed as a GST fusion protein. Cells were washed in PBS
and incubated with a rhodamine (tetramethylrhodamine B isothiocya-
nate)-conjugated affinity-purified goat anti-rabbit IgG (Molecular
Probes) 1:400 dilution with 25% goat serum in PBS. After extensive
washing in PBS, cells were mounted in 50% glycerol in PBS. Specificity
of the anti-CADTK antisera was determined by blocking with purified
GST-CRNK for 1 h at room temperature before use.
Preparation GST Fusion Proteins—GST fusion proteins were grown
and isolated from the expression plasmids pGEX3X (Amersham Phar-
macia Biotech), pGEX3X-C3 (generously provided by Dr. K. Burridge,
University of North Carolina), or pGEX3X-CRNK as described (6).
Protein concentrations were determined by the Bradford method (Bio-
Rad). GST-CRNK was labeled with Oregon green 488 (Molecular
Probes) according to the manufacturer’s recommendations.
Electroporation of GST Fusion Proteins into Monocytes—Monocytes
(1 3 107/ml) were resuspended in intracellular electroporation buffer,
which consisted of 125 mM KOH, 4 mM NaOH, 73 mM PIPES, 10 mM
NaHCO3, 5 mM K2HPO4, 5 mM KH2PO4, 5 mM D-glucose, 4 mM MgCl2,
1 mM MgSO4, 10 mM CaCl2 (pH 7.0) (47). Approximately 2 3 10
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monocytes were electroporated in the presence of 250 mg of purified
GST, GST-CRNK, or GST-C3 proteins in a total volume of 400 ml in a
0.4-cm sterile cuvette at 750 V/cm2. After electroporation, cells were
incubated on ice for 5 min in 1 ml of RPMI 1640 containing 10 mg/ml
polymyxin-B before use. Purified GST has a molecular mass of ;24
kDa. Purified GST-CRNK and GST-C3 have molecular masses of ;42
and 46 kDa, respectively.
Immunoprecipitation—Cells, 5–8 3 106, were adhered, rinsed, and
lysed on ice for 30 min in 50 mM Tris (pH 7.5), 150 mM NaCl, 1% Triton
X-100, 50 mM NaF, 1 mM sodium vanadate, 10 mg/ml leupeptin, 1 mg/ml
aprotinin, and 10 mg/ml phenylmethylsulfonyl fluoride. Lysates were
clarified at 10,000 rpm for 30 min at 4 °C. Equivalent protein concen-
trations were incubated with 5 ml of anti-CADTK antibody for 1 h at
4 °C in the presence of 20 ml of protein-A/protein G-agarose beads.
Beads were washed 3 times in lysis buffer and resuspended in 30 ml of
23 Laemmli sample buffer, boiled, and frozen until use.
Western Transfer Analysis—Whole cell extracts were prepared from
2 3 106 cells by direct lysis into Laemmli buffer. Proteins were resolved
by SDS-10% polyacrylamide gel electrophoresis and analyzed by immu-
noblotting using antibodies that detect the active, phosphorylated
forms of the ERK, JNK, and p38 MAP kinases. The p38 MAP kinase
antibody was obtained from New England Biolabs. Phospho-specific
ERK and JNK antibodies were from Promega and used according to the
manufacturer’s recommendations. Horseradish peroxidase-RC20 (anti-
phosphotyrosine) was obtained from Transduction Labs.
Phagocytosis Assays—Monocytes, 1 3 106, were adhered in the pres-
ence of autologous serum for 30 min and then fed 3 3 105/ml FITC-
conjugated zymosan A (Saccharomyces cerevisiae) bioparticles (Molec-
ular Probes) for 45 min. Extracellular fluorescence was quenched by the
addition of 0.4% trypan blue. The percentage of phagocytosing cells was
determined as the fraction of monocytes with internalized fluorescent
particles from 500 monocytes counted by fluorescence microscopy. Ex-
periments were performed in triplicate and repeated at least twice.
RESULTS
CADTK Concentrates toward the Leading Edge in Migrating,
Polarized Monocytes—To begin tests of the role of CADTK in
monocyte motility, we immunolocalized CADTK under several
conditions. When monocytes were adhered under serum-free
conditions, they failed to polarize and maintained radial sym-
metry (Fig. 1A, M-NM). In contrast, monocytes adhered in the
presence of 5% autologous serum rapidly polarized, generated
multiple small lamellipodia, but then migrated after develop-
ment of a single large lamellipodium (Fig. 1A, M-M). Retraction3 T. W. Harding and H. S. Earp, unpublished observations.
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fibers and filapodia were only observed in motile monocytes.
Indirect immunofluorescence revealed that CADTK localized in
the leading edge of motile monocytes and to the actin ruffles of
both nonpolarized and polarized monocytes (Fig. 1, B and E).
CADTK was detected diffusely throughout the monocyte cyto-
plasm in nonmotile cells, although it also concentrated in the
nuclear cleft. Regions of intense actin staining showed in-
creased localization of CADTK. Although some monocytes dem-
onstrated increased CADTK localization at the adhered sur-
faces, CADTK immunoreactivity was most prominent in the
cortical ruffles of both polarized and nonpolarized cells (Fig. 1,
B and E). CADTK did not apparently localize to podosomes or
points of focal contact, retraction fibers, or filapodia. In con-
trast, as previously shown, (28), CADTK did localize to points
of contact in the large enucleated structures, which are pre-
sumably derived from the platelet precursor, megakaryocytes
(Fig. 1B). CADTK localization was highly specific, as immuno-
staining with antisera that was absorbed with purified, bacu-
loviral-expressed and purified CRNK, which contains the
amino acids used to construct the immunizing GST fusion
peptide, failed to detect any immunoreactivity within the ruf-
fles (data not shown). Another group has also recently pub-
lished data showing that CADTK/Pyk2 localized in the ruffles
of lipopolysaccharide-stimulated human monocytes and mu-
rine macrophages (51).
CADTK Is Required for Monocyte Spreading, Adhesion-in-
duced Phosphorylation and ERK Activation—Localization of
CADTK in the leading edge ruffles reinforced a possible role in
migration and monocyte recruitment. To test this hypothesis, a
GST fusion protein was generated by cloning the C-terminal
region of CADTK, CRNK, (nucleotides 2050–3027) into the
expression vector pGEX3X (36, 49). Purified GST-CRNK has a
molecular mass of ;42 kDa. Coexpression of CADTK and
CRNK in 293T cells (49) or expression in rat liver epithelial or
rat smooth muscle cells inhibits CADTK activation.4 Thus,
CRNK has dominant negative activity.
Monocytes cannot be transfected by conventional methods.
However, high efficiency introduction of recombinant proteins
into cells can be achieved by electroporation (6, 50). We have
recently shown that electroporation is adaptable for primary
monocytes with proteins retaining functional activity over time
(6).
Monocytes were electroporated with ;300 mg of fluorescently
labeled GST-CRNK to assess the uptake efficiency. Electropo-
rated monocytes were extensively washed in cold medium and
cytospin preparations made immediately or cells held at 37 °C
for various time periods. Although uptake distribution was
heterogenous, greater than 90% of monocytes were positive
(Fig. 2A). Monocytes remained viable and retained expression
of the fusion protein even after incubation for 90 min. Similar
results were obtained with other FITC-labeled proteins includ-
ing GST-C3 or with FITC-conjugated dextran (data not shown).
Western blot analysis of monocytes lysed 30 min after electro-
poration and washing revealed comparable protein uptake for
multiple GST fusion proteins (Fig. 2B), GST at ;21 kDa, GST-
CRNK at ;42 kDa, and the GST fusion protein including the
RhoA inhibitor, C3 transferase, at ;46 kDa. Both GST-CRNK
and GST-C3 show some protein degradation after introduction
and adhesion. This was not surprising, as we noted intense
lysosomal staining after the monocytes were electroporated
with the FITC-labeled GST-CRNK.
To test the functionality of GST-CRNK, we assessed both a
direct effect on CADTK phosphorylation and a downstream
consequence of CADTK activation. As previously shown (23),
CADTK is not phosphorylated in freshly isolated nonadherent
monocytes. Adhesion rapidly induced tyrosine phosphorylation
of several proteins including CADTK (Fig. 2C). Electroporation
per se did not interfere with adhesion-induced CADTK tyrosine
phosphorylation; monocytes electroporated with GST alone
showed CADTK phosphorylation comparable with that of un-
electroporated monocytes (compare adherence, ADH, with
GST, Fig. 2D). Electroporation of GST-CRNK, however, inhib-
ited both total adhesion-induced tyrosine phosphorylation as
well as tyrosine phosphorylation of endogenous CADTK with-
out affecting total CADTK levels (Fig. 2, C and D). The inhibi-
tion of tyrosine phosphorylation was similar to that seen with
20 mM genistein.
We recently showed that adhesion rapidly activated ERK
and JNK kinases in monocytes (6). As CADTK/Pyk2 has been
shown to activate ERK, JNK, and p38 MAP kinases in various
cell types (18, 26, 48), we assessed the effects of GST-CRNK on
adhesion-induced MAP kinase activation. GST-CRNK clearly
blocked adhesion-induced ERK activation (Fig. 2E). Although
GST-CRNK had a slight but inconsistent effect on p38 MAP
kinase activation, there was no effect on activated JNK expres-
sion (Fig. 2E). Similar results were obtained whether the in-
hibitory CRNK protein electroporated was from bacteria (GST
or GST-CRNK) or from baculovirus-infected insect cells (GFP
or CRNK) (Fig. 2E). The effect was specific for CRNK as we
detected no modulation of ERK, JNK, or p38 MAP kinase
activation in monocytes electroporated with GST-C3 despite
profound differences in cell morphology and cell spreading (see
below).
4 T. W. Harding, L. M. Graves, and H. S. Earp, unpublished
observations.
FIG. 1. Lamellipodial immunolocalization of CADTK in ad-
hered monocytes. Freshly isolated human monocytes were adhered to
glass coverslips for 30 min in the presence of 5% autologous serum.
Cells were rinsed in PBS, fixed in 4% paraformaldehyde, and processed
for immunofluorescence as described under “Materials and Methods” A,
actin immunofluorescence of monocytes adhered in the absence (left) or
presence of serum (right). P, giant platelet; M-NM, monocyte nonmotile;
M-M, monocyte motile; L, lymphocyte. B, CADTK immunofluorescence
of cells shown in A. C, basal surface of adhered monocytes stained for
actin. D, apical surface of monocytes shown in C stained for actin. E,
apical surface of monocytes shown in C stained for CADTK.
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We recently showed that inhibition of adhesion-induced ty-
rosine phosphorylation with either genistein or the cellular
phosphatase, PTP1B, introduced as GST-PTP1B, can inhibit
monocyte spreading (6). Because GST-CRNK also inhibited
total tyrosine phosphorylation, we assessed the effects on
monocyte adhesion and spreading. Monocytes were adhered
and immunostained for tyrosine phosphorylation (Fig. 3A). In
control GST electroporated monocytes, tyrosine phosphoryla-
tion was seen as a pattern of intense staining around the
nucleus and a distinct continuous ring of peripheral staining in
the ruffling lamellipodia. Phosphotyrosine staining correlated
with that of filamentous actin. In contrast, tyrosine phospho-
rylation appeared random and diffuse in GST-CRNK mono-
cytes, and these cells lacked both the continuous peripheral
edge staining seen in control monocytes and the intense pe-
rinuclear phosphotyrosine staining (Fig. 3A). There was little
correlation between phosphotyrosine staining and actin
localization.
One striking difference between GST-, GST-C3-, and GST-
CRNK-electroporated monocytes was the effect on cell spread-
ing. Although GST-CRNK electroporated cells adhered with
similar efficiency to those electroporated with GST, spreading
was markedly compromised (Fig. 3B). Using the NIH Image
software, we quantitated spreading by measuring the total
surface area occupied by each cell. Approximately 50% of mono-
cytes electroporated with GST occupied a surface area of at
least 2000 pixels. In contrast, less than 20% of GST-CRNK
monocytes were well spread (.2000 pixels), with the majority
of GST-CRNK monocytes occupying a surface area of less than
2000 pixels. As a positive control for modifying cell spreading,
we electroporated monocytes with the RhoA inhibitor C3 trans-
ferase (52). Monocytes electroporated with GST- C3 demon-
strated profound cell flattening and increased cell spreading,
with almost 70% of cells having an area of .2000 pixels (Fig.
3B). Thus, electroporation of a GST protein does not, by itself,
FIG. 2. High efficiency uptake of GST-CRNK inhibits adhesion-
induced CADTK autophosphorylation and ERK activation. A,
monocytes were electroporated with 300 mg of purified FITC-labeled
GST-CRNK protein and sequentially washed 43 in cold serum-free
media, and cytospin preparations were made. Electroporation of FITC-
labeled GST-CRNK resulted in .90% positive cells detectable within
minutes. A representative experiment is shown (n 5 3). B, monocytes
were electroporated with GST, GST-CRNK, or GST-C3 and adhered for
30 min. Western blot analysis was performed on whole cell lysates for
expression of the GST-tag. CTRL, control. C, monocytes were electro-
porated, and Western blot analysis was performed on both nonadhered
(NAD) and adhered monocytes (GST-CRNK, Genistein) for total phos-
photyrosine. As a control, monocytes were treated with genistein (20
mM) for 20 min before adhesion. D, monocytes were electroporated with
GST or GST-CRNK and adhered for 30 min, and CADTK was immu-
noprecipitated (IP) as described previously (20). Equivalent protein
concentrations were loaded, and proteins were separated by 10% SDS-
polyacrylamide gel electrophoresis. Blots were sequentially probed for
phosphotyrosine and CADTK. NAD, nonadherent monocytes; ADH,
adherent monocytes; GN/A, GN4 rat smooth muscle cells stimulated
with angiotensin II. pTyr, phosphorylated tyrosine. E, adhesion-in-
duced ERK activation was inhibited by GST-CRNK. Monocytes were
electroporated with either GST fusion proteins (GST, GST-CRNK, or
GST-C3), or with baculoviral-produced recombinant proteins, adhered
for 30 min in serum-free medium. Western blot analysis was performed
with phospho-specific antibodies for ERK, p38, or JNK MAP kinases.
E. coli, Escherichia coli.
FIG. 3. GST-CRNK alters phosphotyrosine localization and
cell spreading. A, GST-CRNK alters phosphotyrosine localization in
monocytes away from the peripheral edge. Monocytes were electropo-
rated with GST or GST-CRNK, adhered for 30 min, fixed in 3%
paraformaldehyde-sucrose, and immunostained for phosphotyrosine as
described under “Materials and Methods.” B, monocytes electroporated
with either GST, GST-C3, or GST-CRNK were adhered for 30 min, fixed
in 3% PFA-S, and stained with hematoxylin-eosin. The area was deter-
mined by phase light microscopy using a 403 lens and the NIH Image
Scion 1.6 software. At least 150 cells were measured per sample. Bars 5
mean 6 S.D. of triplicate samples. A representative experiment of five
experiments is shown. pTyr, phosphorylated tyrosine.
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inhibit cell spreading. In other experiments we showed that cell
spreading was neither inhibited by the MEK1/2 (mitogen-acti-
vated protein kinase/extracellular signal-regulated kinase ki-
nase 1/2) inhibitor PD 98059 nor the p38 MAP kinase inhibitor
SB 203580, suggesting that the absence of activation of these
kinases is not directly responsible for the alteration in the
cytoskeletal organization seen in GST-CRNK monocytes (data
not shown).
CADTK Is Critical for Monocyte Motility but Not Phagocyto-
sis nor Adhesion-induced Cytokine Gene Expression—Mono-
cytes exhibit chemokinetic motility when cultured in the pres-
ence of autologous serum (9, 10). Because CADTK localized to
the leading edge lamellipodia and membrane ruffles and is
activated by chemokines (23), we assessed the motility by time-
lapse photography of monocytes electroporated with either
GST, GST-CRNK, or GST-C3 proteins and adhered to glass
slides in the presence of 5% autologous serum. Data from an
experiment superimposing the first and last frames over 25
min of monocyte motility are displayed in Fig. 4. GST-electro-
porated cells exhibited motility for greater than 20 min and
covered distances of several cell diameters during this time. In
contrast, although continuing to ruffle and bleb, GST-CRNK-
electroporated monocytes failed to migrate. Quantification of 5
independent experiments revealed that only an average 26.0 6
17.9% (range 10–50%) of monocytes electroporated with GST-
CRNK exhibited motility. Motility in monocytes electroporated
with GST was demonstrable in 82.3 6 12.5% (range 70–100%)
of cells. Although the leading edges of GST-C3-electroporated
monocytes were highly motile, allowing the majority of the cell
to move up to several diameters, the tails failed to retract. This
indicates that GST proteins that have distinct effects on mono-
cyte cytoskeletal organization also have distinct effects on
motility.
To determine whether GST-CRNK was inhibiting other
monocyte functions, we examined the role of CADTK in phag-
ocytosis and adhesion-induced gene induction. Electroporated
cells were adhered in the presence of autologous serum for 1 h
and then fed fluorescent zymosan yeast particles for 45 min,
fixed, and analyzed. Random fields were chosen by light mi-
croscopy and then subjected to fluorescence to avoid bias in
data collection. Although GST-CRNK had marked effects on
monocyte spreading and motility, phagocytosis was unim-
paired by the electroporated protein (Fig. 5). There was no
significant difference between GST-, GST-C3-, and GST-
CRNK-electroporated monocytes in the percentage of cells ca-
pable of phagocytosis.
Monocyte adhesion and spreading are associated with the
rapid (within 5 min) transcriptional activation of a variety of
cytokine genes (4–6). Because these events occur consequen-
tial to profound changes in cytoskeletal organization, we were
interested in determining whether GST-CRNK modulation of
monocyte spreading also interferes with adhesion-induced cy-
tokine gene induction. As previously reported (5, 6), nonad-
hered monocytes do not spontaneously express interleukin-1b
mRNA transcripts (Fig. 5B). Adhesion resulted in the induction
of interleukin-1b mRNA after electroporation with GST, GST-
CRNK, or GST-C3. These results suggest that CADTK,
whereas important in monocyte cytoskeletal organization and
motility, plays a limited, if any, role in the functional activities
of phagocytosis or adhesion-induced gene induction.
FIG. 4. GST-CRNK inhibits monocyte motility. Monocytes were
electroporated either with GST, GST-C3, or GST-CRNK and adhered in
the presence of 5% autologous serum. Motility was monitored by light
microscopy using a 403 objective and the NIH Image 1.6 Movie soft-
ware. Monocytes were followed over 70 frames. The first and last
frames were combined to show cell movement. The arrow denotes
direction of motility from the first frame to the last. The asterisk
denotes nonmotile cell. A representative of five experiments is shown.
FIG. 5. GST-CRNK does not inhibit monocyte phagocytosis or
adhesion-induced gene expression. A, monocytes were adhered in
the presence of 5% autologous serum for 45 min and then fed FITC-
labeled zymosan bioparticles for 45 min. Cells were washed twice in
PBS and incubated with 0.4% trypan blue to quench extracellular
fluorescence from unphagocytosed particles. At least 100 cells were
counted per sample. Bars represent mean 6 S.D. of triplicate samples.
A representative of three experiments is shown. B, monocytes were
electroporated and adhered in the presence of autologous serum for 45
min, and total RNA was isolated. Northern analysis was performed on
1 mg of total RNA/lane, and the blot was probed sequentially for inter-
leukin-1b and b -actin.
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DISCUSSION
Freshly isolated peripheral blood monocytes do not make
typical focal adhesions or actin stress fibers nor do they express
p125FAK. Monocytes do express the closest known orthologue
tyrosine kinase, CADTK. These highly related signaling mole-
cules are expressed together in many cell types and presum-
ably have distinct but perhaps complementary functions. The
specific biology of monocytes apparently allow it to dispose with
p125FAK and rely on a single cytoskeletal-associated kinase
from this family, CADTK. In monocytes, CADTK does not
localize to contact points upon adherence but, instead, localizes
to the ruffling lamellipodial structures. As shown in Fig. 1 and
as recently published by Williams and Ridley (51), CADTK/
Pyk2 localized to the leading lamellipodia and ruffling mem-
branes of adhered motile monocytes (Fig. 1) and lipopolysac-
charide-stimulated monocytes and macrophages.
CADTK/Pyk2/CAKb/RAFTK/FAK2 and p125FAK are mem-
bers of a kinase family, at least one of which is expressed in
virtually all cell types. For example, most fibroblasts express
only p125FAK, epithelial and neuronal cells express both
p125FAK and CADTK, and monocytes express only CADTK.
CADTK is expressed throughout the hematopoetic lineages
including monocytes (23, 24, 29), megakaryocytes (45), plate-
lets (46–47), NK cells (34, 40–41), granulocytes (42), and both
T and B lymphocytes (37–39). In monocytic cells, CADTK is
predominately expressed as a splice variant that deletes one of
the proline-rich regions, yielding a protein of ;110 kDa (23).
CADTK shares topological similarities with p125FAK (49), al-
though one striking difference is the lack of localization to focal
adhesions when overexpressed in chicken and other fibroblasts
(36). Monocytes lack traditional focal adhesions but form focal
contacts sites, termed podosomes, when cultured under condi-
tions that stimulate motility. Whereas CADTK localized to the
monocyte cortical ruffles, it did not localize to the podosome
structures.
CADTK is rapidly phosphorylated upon adhesion in mono-
cytes, megakaryocytes, and platelets and when overexpressed
in COS cells (23, 28, 46–47). Additionally, CADTK can be
tyrosine-phosphorylated after engagement of integrins (23, 44,
53), integrin-dependent platelet aggregation (46), or by activa-
tion of either the T cell receptor complex or the B cell antigen
receptor complex (37, 39, 53, 54). Activation of CADTK in
platelets results in its translocation from the cytosol to the
cytoskeleton (46). In most hematopoetic cells, cytoskeletal or-
ganization is critical to CADTK tyrosine phosphorylation be-
cause treatment with cytochalasin D to disrupt the actin cy-
toskeleton inhibits CADTK phosphorylation (27, 30, 53). We
have recently shown that monocyte cytoskeletal organization
can be dramatically disrupted by the introduction of the phos-
phatase PTP1B (GST-PTP1B) or by treatment with tyrosine
kinase inhibitor, genistein (6). Here we have identified adhe-
sion-induced tyrosine phosphorylation of CADTK as having a
regulatory role in monocytic cytoskeletal organization. Inhibi-
tion of adhesion-induced CADTK autophosphorylation by the
introduction of GST-CRNK blocked cell spreading and dis-
rupted the distribution of tyrosine-phosphorylated proteins in
adhered monocytes, presumably by displacing CADTK. We had
previously shown that cotransfection of CRNK can block
CADTK activation (49). However, transfection is not suitable
for introduction of genes into monocytes, and we used electro-
poration as a means to introduce GST-CRNK into freshly iso-
lated monocytes. FITC-labeling of GST-CRNK and other GST
proteins showed the utility and efficiency (.90% of cells) of this
method. The amount of GST-CRNK electroporated into mono-
cytes is easily detectable in lysates and exceeds the amount of
CADTK. When immunofluorescence was performed on GST-
CRNK electroporated cells, the protein was widely distributed
and did not just localize to structures binding CADTK. How-
ever, introduction of GST, GST-C3, or GST-PTP1B (6) produced
similar or greater levels of protein than GST-CADTK; all
served as controls showing the specificity of the GST-CRNK
biologic effect. The specific changes in motility are only seen
with CRNK and are clearly not simply due to introduction of a
range of proteins.
Preliminary experiments indicate that introduction of GST
FRNK also blocks monocyte motility. FAK is not expressed in
monocytes; however, we have shown using liver epithelial cells,
rat smooth muscle cells, and human embryonic kidney cells
that over expression of FRNK disrupts both FAK and CADTK
signaling. Therefore, it was not a surprise that the high level of
GST-FRNK obtained by electroporation blocked CADTK func-
tion. We believe that FRNK disrupts the “cytoskeletal engage-
ment” step (23), which we have hypothesized is involved in
CADTK activation in cells. Since FAK has no direct role in
these cells, FRNK introduction may inhibit some processes
simply by binding to CADTK-binding proteins with motifs sim-
ilar to its other cell binding partners.
The present data, in addition to our previous observations
with GST-PTP1B and genistein, highlight the interrelation
between adhesion-dependent tyrosine phosphorylation and cy-
toskeletal organization in monocytes. They suggest that
CADTK activation is important in triggering these tyrosine
phosphorylation events but do not prove that CADTK alone is
responsible. Decreases in adhesion-dependent monocyte tyro-
sine phosphorylation are also seen in Hck and Fgr double
knockout macrophage cells (55). Thus src family members
could be upstream or downstream of CADTK in monocyte ad-
hesion-signaling events.
Introduction of GST-CRNK into monocytes not only inhib-
ited CADTK tyrosine phosphorylation but also led to a more
global loss and lack of cellular redistribution of other phospho-
tyrosine-containing proteins. GST-CRNK but not GST inter-
fered with monocyte cytoskeletal reorganization, as indicated
by lack of spreading and motility. The identity of the CADTK
tyrosine-phosphorylated proteins key to these events is un-
known. However, CADTK can interact with and/or phosphoryl-
ate several signaling-associated proteins in a variety of cells;
these include Grb2, Src family tyrosine kinases, p130Cas, Crk
(56), paxillin (30), and SHPS-1 (57) in numerous cell types
including THP-1 promonocytic cells and epithelial cells (29, 30).
A particularly interesting substrate is the abundant paxillin
family member leupaxin, which is present in monocytes and
which has been demonstrated to bind to CADTK (32). Leupaxin
as a tyrosine-phosphorylated monocyte cytoskeletal protein
may be an important target disrupted by the introduction of
GST CRNK.
CADTK has also been linked to other signaling pathways
including activation of the MAP kinases. Monocyte adhesion
resulted in the activation of ERK and JNK kinases (6). Intro-
duction of GST-CRNK blocked ERK activation but not JNK
activation, suggesting that in monocytes, CADTK is an up-
stream mediator of ERK activation. This has also been sug-
gested for other cell types including NK cells (41). The conse-
quences of inhibiting ERK activation in monocytes are not
readily apparent. We have previously shown that a loss of ERK
activation rapidly effects adhesion-induced cytokine mRNA
stability without significantly inhibiting gene transcription (6).
Here we have confirmed the observation that ERK activation is
dispensable for adhesion-induced transcriptional activation of
interleukin-1b mRNA by inhibiting its activation through
CRNK introduction. Thus, CADTK activation appeared to be
dispensable for adhesion-induced gene induction but not for
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adhesion-induced ERK activation.
We have observed that the pharmacologic inhibitor of MEK1/
2(mitogen-activated protein kinase/extracellular signal-regu-
lated kinase kinase 1/2), PD 98059, inhibited neither cell
spreading nor cell motility despite a loss of ERK activation in
primary monocytes5 or primary bone marrow CD341 progeni-
tor cells (8). Thus in monocytes, CADTK-induced activation of
ERK is probably not a primary mechanism by which CADTK is
involved in cell motility.
CADTK overexpression in fibroblasts (cells that do not nor-
mally express CADTK) does not result in cytoskeletal associa-
tion and often results in cell rounding and apoptosis (25). This
is despite the facts that CADTK contains a focal adhesion
targeting region that closely resembles p125FAK and that
CADTK binds paxillin with similar affinity to that of p125FAK
(30) as well as Hic-5 and leupaxin (31–32). Clearly there are
other complexities to CADTK cytoskeletal association. For ex-
ample, in rat smooth muscle cells, which normally express both
p125FAK and CADTK, CADTK is localized to the actin cytoskel-
eton. In mouse embryo fibroblasts derived from FAK 2/2
knockout animals, CADTK/Pyk2 protein is expressed, an un-
usual occurrence in fibroblasts, and yet motility is not restored
by the compensatory CADTK expression (15, 16); furthermore,
in these cells, CADTK/Pyk2 is localized not to the cytoskeleton
but to perinuclear bodies.3 Thus the ability of CADTK to par-
ticipate or govern motility appears to require a cell type in
which it is capable of localizing to cytoskeletal elements, per-
haps through the expression of a specific CADTK cytoskeletal
linker protein.
In summary, our results implicate CADTK as a critical in-
termediary of monocyte motility. Our previous results that
introduction of a tyrosine phosphatase PTP1B also inhibits
motility (6) and the fact that macrophages derived from mice
deficient in the related Src kinases, Hck and Fgr, also exhibited
severely retarded motility (56) add to the evidence that tyro-
sine phosphorylation regulates monocyte motility. The macro-
phages from Hck and Fgr 2/2 mice failed to localize paxillin,
talin, and filamentous actin to the leading lamellipodia, all
contributing to reduced motility (56). CADTK is activated by
adhesion, autophosphorylates on tyrosine 402 (49), a site that
binds src family SH2 groups, and might regulate Hck and Fgr
activity. Taken together, our results suggest that the in vivo
consequences of preventing CADTK activation and/or function,
like that of Hck and Fgr, would be defective localization of
monocytes to sites of inflammation.
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